National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 519659

Case Details

VAERS ID: 519659 (history)  
Age: 13.0  
Gender: Female  
Location: Foreign  
Vaccinated:2011-02-04
Onset:0000-00-00
Submitted: 2014-01-16
Entered: 2014-01-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. NK47540 / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: CSF test abnormal, Cataplexy, Fatigue, Narcolepsy, Sleep study abnormal
SMQs:, Convulsions (broad), Guillain-Barre syndrome (broad), Generalised convulsive seizures following immunisation (broad)

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: 09/02/2010, GARDASIL, Immunisation, (Batch number unknown an can not be provided) via intramuscular route of administration in not reported site of administration; 07/05/2010, GARDASIL, Immunisation, (Batch number unknown an can not be provided) via intramuscular route of administration in not reported site of administration
Diagnostic Lab Data: Unknown date: CSF test: Low hypocretin (<10) HLA-DQB*0602; Unknown date: Polysomnography: Short average sleep latency (30 seconds); Unknown date: Multiple sleep latency test: Short average sleep latency (30 seconds); Unknown date: Sleep study: SOREM (sleep onset REM) in 4 out of 5 periods.
CDC Split Type: WAES1401DNK005526

Write-up: Information has been received from a physician via SPMSD as part of a business agreement (Sender''s case report number DK-1577272925-E2014-00144) on 13-JAN-2014. Case of adverse event received from a health care professional via Health Authorities on 09-Jan-2014 under the reference number DK-DKMA-ADR 22377196 and DK-DKMA-EFO7893. The primary reporter was a physician. A 13 years-old female patient (weight: 58 kg; height: 167 cm), had received the third dose of GARDASIL (batch number NM46920, lot number NK47540, exp. 31-MAY-2012) via intramuscular route of administration in not reported site of administration on 04-Feb-2011 and later on, unspecified date in Feb-2011, she developed narcolepsy. In addition, on an unspecified date after the third vaccination, she developed persistent tiredness and three months later she experienced narcolepsy with cataplexy (hypocretin deficiency). Patient medical history is unknown. The patient had received two previous doses of GARDASIL (batch numbers are unknown and cannot be provided) via intramuscular route of administration in not reported site of administration on 05-Jul-2010 and 02-Sep-2010. It is unknown if the patient had other vaccines or medications. Test of spinal fluid showed low hypocretin (<10) HLA-DQB*0602. Polysomnography and MSLT (multiple sleep latency test) showed short average sleep latency (30 seconds). SOREM (sleep onset REM) was in 4 out of 5 periods. At the time of reporting, the outcome was unknown for persistent tiredness and narcolepsy with cataplexy. Outcome was not recovered for narcolepsy.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=519659


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166